Lingohr & Partner Asset Management Gmb H Bio N Tech Se Transaction History
Lingohr & Partner Asset Management Gmb H
- $55.2 Million
- Q2 2025
A detailed history of Lingohr & Partner Asset Management Gmb H transactions in Bio N Tech Se stock. As of the latest transaction made, Lingohr & Partner Asset Management Gmb H holds 6,822 shares of BNTX stock, worth $723,473. This represents 1.32% of its overall portfolio holdings.
Number of Shares
6,822
Previous 43,031
84.15%
Holding current value
$723,473
Previous $3.92 Million
81.47%
% of portfolio
1.32%
Previous 0.98%
Shares
3 transactions
Others Institutions Holding BNTX
# of Institutions
318Shares Held
40.8MCall Options Held
1.37MPut Options Held
1.52M-
Baillie Gifford & CO8.04MShares$853 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$449 Million1.88% of portfolio
-
Primecap Management CO Pasadena, CA4MShares$424 Million0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.6MShares$382 Million0.24% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$201 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.7B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...